Listed Company

Clinuvel Pharmaceuticals Limited (ASX CUV)


Followers 43
Exchange ASX
Sector Health Care
Industry Pharmaceuticals, Biotechnology & Life Sciences

Latest on CLINUVEL PHARMACEUTICALS LIMITED


Covering Clinuvel Pharmaceuticals Limited


James Gerrish
Market Matters
Marcus Padley
Marcus Today
Kingsley Jones
Jevons Global
Michael Frazis
Frazis Capital
Claire Aitchison
Independent Investment Research
Gary Rollo
Montgomery

Clinuvel Pharmaceuticals Limited (ASX:CUV) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is CUV. Livewire Markets has 8 experts who have published 8 articles that have featured Clinuvel Pharmaceuticals Limited. You can view all those wires here. The last time time CUV was featured was on the 21 October 2022 by Ally Selby in the wire “Calcutta 2023: Australia's brightest investors name 17 top stocks for the year ahead”.

trending on livewire
Get the best of Livewire by signing up to our popular daily newsletter